PEN Stock Summary and Trading Ideas (Penumbra | NYSE:PEN)

Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.

Penumbra trades on the NYSE stock market under the symbol PEN.

As of June 11, 2026, PEN stock price declined to $318.32 with 315,356 million shares trading.

PEN has a beta of -0.52, meaning it tends to be less sensitive to market movements. PEN has a correlation of 0.05 to the broad based SPY ETF.

PEN has a market cap of $12.52 billion. This is considered a Large Cap stock.

Last quarter Penumbra reported $375 million in Revenue and $1.01 earnings per share. This beat revenue expectation by $3 million and missed earnings estimates by -$.07.

In the last 3 years, PEN traded as high as $362.41 and as low as $148.00.

The top ETF exchange traded funds that PEN belongs to (by Net Assets): IJH, VTI, VB, VBK, VXF.

PEN has outperformed the market in the last year with a price return of +24.5% while the SPY ETF gained +23.6%. However, in the short term, PEN had mixed performance relative to the market. It has underperformed in the last 3 months, returning -5.5% vs +9.2% return in SPY. But in the last 2 weeks, PEN shares have fared better than the market returning -0.6% compared to SPY -1.7%.

PEN support price is $317.33 and resistance is $321.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PEN shares will trade within this expected range on the day.